Includes bibliographical references (p. 131-135) and index.
Summary
Looks at rare diseases, such as Tay-Sachs, cystic fibrosis, and sickle-cell anemia, which are neglected by researchers and drug manufacturers for fiscal, political, and practical reasons.
